Clinical trial
Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue
NCT01551563 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Management of Inflammatory Bowel Disease in the Stavanger Area - a Prospective Evaluation of Standardized Treatment Regimens on Disease Outcome With Focus on Mucosal Healing and Associations to Fatigue
- Lead sponsor
- Helse Stavanger HF
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 30, 2012
- Completion date
- December 31, 2030
- Enrollment
- 700 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ibd